Profound Medical Corp.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Tom MalinowskiHouse · D · NJ |
PROFProfound Medical Corp. · Stock |
Purchase $1,001 - $15,000 |
Aug 26, 2021 | Jan 14, 2020 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
PROFProfound Medical Corp. · Stock |
Purchase $1,001 - $15,000 |
Aug 26, 2021 | Jan 27, 2020 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
PROFProfound Medical Corp. · Stock |
Purchase $1,001 - $15,000 |
Mar 5, 2021 | Dec 20, 2019 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
PROFProfound Medical Corp. · Stock |
Purchase $1,001 - $15,000 |
Mar 5, 2021 | Jul 21, 2020 | Filing ↗ |
Whale Activity
- Increased14
- New7
- Held18
- Decreased15
- Closed6
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| FIL Ltd | 2.4M | $13.9M | increased |
| GAGNON SECURITIES LLC | 2.1M | $11.9M | — |
| ROYCE & ASSOCIATES LP | 1.2M | $7.1M | increased |
| Timelo Investment Management Inc. | 1.0M | $5.9M | decreased |
| Gagnon Advisors, LLC | 962.2K | $5.6M | held |
| LETKO, BROSSEAU & ASSOCIATES INC | 935.7K | $5.2M | held |
| Rosalind Advisors, Inc. | 828.1K | $4.8M | held |
| Z3 Capital Partners, LLC | 783.1K | $4.5M | decreased |
| MMCAP International Inc. SPC | 671.4K | $3.9M | held |
| ARDSLEY ADVISORY PARTNERS LP | 575.0K | $3.3M | held |
| Lagoda Investment Management, L.P. | 536.9K | $3.1M | increased |
| Ring Mountain Capital, LLC | 521.1K | $3.0M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Menawat Arun SwarupCEO · Director | Purchase | +12.0K | $4.73 | $57K | May 16, 2025 | Form 4 ↗ |
| Menawat Arun SwarupCEO · Director | Purchase | +10.0K | $4.33 | $43K | May 15, 2025 | Form 4 ↗ |
| HOFER MICHAELDirector | Sale | −40.0K | $0.16 | $6K | Dec 20, 2012 | Form 4 ↗ |
| HOFER MICHAELDirector | Purchase | −40.0K | $0.16 | $6K | Dec 18, 2012 | Form 4 ↗ |
| SVEINSON FREDERICK JDirector | Purchase | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| TEJADA FREDDirector | Purchase Amended | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| BLANCHET JUSTINChief Financial Officer · Director | Purchase Amended | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| ALIKAJ PERPARIMDirector | Purchase Amended | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| KHORCHIDIAN RAFFI10% owner | Sale | −3.0M | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| KHORCHIDIAN RAFFI10% owner | Other | −52.0M | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| Schweitzer John H.Pres., CEO, Sec., Treas. · Director | Purchase | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| HOFER MICHAELDirector | Purchase | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| ALIKAJ PERPARIMDirector | Gift | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| BLANCHET JUSTINChief Financial Officer · Director | Gift | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
| TEJADA FREDDirector | Gift | +500.0K | $0.00 | $0 | Jun 19, 2012 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| ROYCE MICRO-CAP TRUST, INC. | 742.8K | $4.9M | 0.54% | Jun 30, 2026 |
| First Eagle Small Cap Opportunity Fund First Eagle Funds | 398.0K | $2.9M | 0.10% | Jul 31, 2026 |
| Royce Micro-Cap Fund ROYCE FUND | 343.9K | $2.3M | 0.53% | Jun 30, 2026 |
| Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND | 112.9K | $751K | 0.53% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 26.7K | $181K | 0.00% | Aug 31, 2026 |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 16.4K | $112K | 0.50% | Aug 31, 2026 |
| The Canadian Small Company Series DFA INVESTMENT TRUST CO | 4,590 | $34K | 0.00% | Jul 31, 2026 |
| INTERNATIONAL CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 3,806 | $28K | 0.00% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF Dimensional ETF Trust | 1,891 | $14K | 0.00% | Jul 31, 2026 |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 908 | $7K | 0.00% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list PROF's shares (CUSIP 74319B502), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming Profound Medical Corp. as the client.
Government Contracts
No federal contract awards found for Profound Medical Corp..
U.S. Patents
No USPTO patent applications found for Profound Medical Corp..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $16.1M | $10.7M | $7.2M |
| Operating income | -$41.3M | -$33.1M | -$28.7M |
| Net income | -$42.6M | -$27.8M | -$28.3M |
| Diluted EPS | $1.41 | $1.12 | $1.34 |
| Operating cash flow | -$38.2M | -$23.5M | -$22.6M |
| Cash and equivalents | $59.7M | $54.9M | $26.2M |
| Total assets | $77.5M | $70.2M | $44.0M |
| Total liabilities | $11.0M | $9.8M | $12.7M |
| Shareholders' equity | $66.4M | $60.4M | $31.2M |
As Profound Medical Corp. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 5, 2026 ↗
Stock Splits
- 1-for-10Reverse splitOct 16, 2019
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 5.02Officer / director changeNov 12, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureNov 9, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureNov 3, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureOct 22, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureOct 14, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureOct 9, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsOct 7, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureSep 4, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 3, 2026
EDGAR ↗

